Conference / Tradeshow

4th Annual Advances in Immuno-Oncology USA Congress


Monday, February 7, 2022 - Tuesday, February 8, 2022


San Diego, CA & Virtual
Attendee at 4th Annual Advances in Immuno-Oncology USA Congress

Event Overview

Join us at the 4th Annual Advances in Immuno-Oncology USA Congress. This three-day congress will be presented in a hybrid format, with two in-person days in San Diego, followed by a digital day on February 9, 2022. The event will have four main areas of focus:

  • Discovery & Development: Cell Therapies & Antibody Approaches
  • Biomarkers in Immuno-Oncology
  • Discovery & Development: Intratumoural Immunotherapies & Combination Strategies
  • Translational & Preclinical Development

Matthew Hewitt Headshot

Matthew Hewitt
Director of Scientific Services
Cell and Gene Therapy,

Charles River Laboratories

Featured Presentation:
State of the Nation in Cell & Gene Therapy: Navigating the Journeys Within the Journey

  • Current cell and gene therapy program development and manufacturing scenarios
  • Program bottlenecks which can derail timelines and how to mitigate them
  • Considerations of an end-to-end integrated CGT portfolio versus a more fragmented approach
  • Glimpse into how the field continues to evolve for regulatory, manufacturing, analytics (QA/QC)